NCT07390396 Effect of Adding Extracorporeal Shock Wave Therapy to Exercises in Rotator Cuff Tendinopathy
| NCT ID | NCT07390396 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Deraya University |
| Condition | Rotator Cuff Tendinopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-12-15 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rotator cuff tendinopathy (RCT) is one of the most common causes of shoulder pain, resulting in functional limitations and reduced quality of life. Exercise therapy is considered a first-line treatment; however, adjunct modalities such as extracorporeal shock wave therapy (ESWT) may enhance recovery. This study aims to evaluate the effect of adding ESWT to a rotator cuff and scapular stabilization exercise program in patients with rotator cuff tendinopathy.
Eligibility Criteria
Inclusion Criteria: * Medically stable individuals who consent to participate in the study. * Male and female participants aged between 30 and 55 years. * Diagnosed with rotator cuff tendinopathy, confirmed clinically and by ultrasound or MRI. * Duration of symptoms greater than 3 months. * Supraspinatus tendon thickness \> 5.85 mm as measured by ultrasound (based on Hunter et al., 2021). * Able to follow the treatment plan and attend all therapy sessions. Exclusion Criteria: * Massive rotator cuff tear or complete tendon rupture. * Adhesive capsulitis or significant limitation of passive shoulder motion. * History of shoulder fracture, dislocation, or surgery in the affected limb. * Rheumatoid arthritis, diabetes mellitus, or systemic inflammatory disease. * Cervical radiculopathy or neurological involvement affecting the shoulder. * Corticosteroid injection in the affected shoulder within the last 6 months. * Pregnancy or breastfeeding. * BMI \> 30 kg/m² (obese individuals excluded). * Current malignancy, open wounds, or local infection at the treatment site. * Inability to tolerate shock wave therapy or perform exercise sessions.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07390396 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 55 Years, studying Rotator Cuff Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07390396 currently recruiting?
Yes, NCT07390396 is actively recruiting participants. Contact the research team at aliaa.gamal@deraya.edu.eg for enrollment information.
Where is the NCT07390396 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT07390396 clinical trial?
NCT07390396 is sponsored by Deraya University. The trial plans to enroll 50 participants.